Agenus (AGEN) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Agenus Revenue Highlights

Latest Revenue (Y)

$103.46M

Latest Revenue (Q)

$24.07M

Main Segment (Y)

Non Cash Royalty Revenue

Main Geography (Y)

UNITED STATES

Agenus Revenue by Period

Agenus Revenue by Year

Date	Revenue	Change
2024-12-31	$103.46M	-33.81%
2023-12-31	$156.31M	59.47%
2022-12-31	$98.02M	-66.85%
2021-12-31	$295.67M	235.34%
2020-12-31	$88.17M	-41.24%
2019-12-31	$150.05M	307.92%
2018-12-31	$36.78M	-14.21%
2017-12-31	$42.88M	89.95%
2016-12-31	$22.57M	-9.04%
2015-12-31	$24.82M	255.70%
2014-12-31	$6.98M	129.13%
2013-12-31	$3.04M	-80.92%
2012-12-31	$15.96M	479.18%
2011-12-31	$2.76M	-17.97%
2010-12-31	$3.36M	0.77%
2009-12-31	$3.33M	25.76%
2008-12-31	$2.65M	-52.25%
2007-12-31	$5.55M	702.20%
2006-12-31	$692.13K	9.87%
2005-12-31	$629.98K	-10.90%
2004-12-31	$707.07K	-84.11%
2003-12-31	$4.45M	30.43%
2002-12-31	$3.41M	-25.10%
2001-12-31	$4.55M	929.08%
2000-12-31	$442.63K	342.63%
1999-12-31	$100.00K	-

Agenus generated $103.46M in revenue during NA 2024, up -33.81% compared to the previous quarter, and up 68.95% compared to the same period a year ago.

Agenus Revenue by Quarter

Date	Revenue	Change
2025-03-31	$24.07M	-10.33%
2024-12-31	$26.84M	6.87%
2024-09-30	$25.11M	6.82%
2024-06-30	$23.51M	-16.05%
2024-03-31	$28.00M	-66.58%
2023-12-31	$83.80M	244.66%
2023-09-30	$24.31M	-3.88%
2023-06-30	$25.30M	10.45%
2023-03-31	$22.90M	-19.32%
2022-12-31	$28.39M	24.65%
2022-09-30	$22.77M	8.82%
2022-06-30	$20.93M	-19.33%
2022-03-31	$25.94M	28.03%
2021-12-31	$20.26M	-91.99%
2021-09-30	$252.95M	2257.45%
2021-06-30	$10.73M	-8.44%
2021-03-31	$11.72M	-62.52%
2020-12-31	$31.26M	110.79%
2020-09-30	$14.83M	-44.95%
2020-06-30	$26.95M	78.11%
2020-03-31	$15.13M	-56.15%
2019-12-31	$34.50M	73.02%
2019-09-30	$19.94M	26.89%
2019-06-30	$15.71M	-80.33%
2019-03-31	$79.89M	1138.53%
2018-12-31	$6.45M	-49.62%
2018-09-30	$12.80M	-19.45%
2018-06-30	$15.89M	871.53%
2018-03-31	$1.64M	-80.42%
2017-12-31	$8.35M	148.68%
2017-09-30	$3.36M	-20.15%
2017-06-30	$4.21M	-84.39%
2017-03-31	$26.96M	383.43%
2016-12-31	$5.58M	25.42%
2016-09-30	$4.45M	-32.55%
2016-06-30	$6.59M	10.62%
2016-03-31	$5.96M	-21.99%
2015-12-31	$7.64M	11.55%
2015-09-30	$6.85M	7.39%
2015-06-30	$6.38M	61.30%
2015-03-31	$3.95M	144.16%
2014-12-31	$1.62M	3.57%
2014-09-30	$1.56M	-49.14%
2014-06-30	$3.07M	326.45%
2014-03-31	$720.86K	83.62%
2013-12-31	$392.58K	-46.66%
2013-09-30	$735.99K	-8.84%
2013-06-30	$807.40K	-27.21%
2013-03-31	$1.11M	1.75%
2012-12-31	$1.09M	25.48%
2012-09-30	$868.80K	38.61%
2012-06-30	$626.79K	-95.31%
2012-03-31	$13.37M	1977.57%
2011-12-31	$643.78K	-1.51%
2011-09-30	$653.68K	-16.88%
2011-06-30	$786.43K	17.05%
2011-03-31	$671.88K	-32.38%
2010-12-31	$993.56K	59.11%
2010-09-30	$624.45K	-22.45%
2010-06-30	$805.17K	-14.02%
2010-03-31	$936.43K	71.26%
2009-12-31	$546.79K	-39.01%
2009-09-30	$896.46K	-29.40%
2009-06-30	$1.27M	104.37%
2009-03-31	$621.35K	19.13%
2008-12-31	$521.58K	-23.81%
2008-09-30	$684.57K	15.11%
2008-06-30	$594.71K	-30.05%
2008-03-31	$850.22K	-4.82%
2007-12-31	$893.29K	-

Agenus generated $24.07M in revenue during Q1 2025, up -10.33% compared to the previous quarter, and up 28.72% compared to the same period a year ago.

Agenus Revenue Breakdown

Agenus Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Non Cash Royalty Revenue	$100.98M	$114.57M	-	-	-
Other	$2.00M	-	-	-	-
License Fee Revenue	-	$25.00M	-	-	-
Research And Development Revenue	-	-	$1.60M	$1.20M	$700.00K
Non Cash Royalty Revenue Related To The Sale Of Future Royalties And Milestone	-	-	$45.28M	$47.55M	-
Product And Service Other	-	-	-	$184.00K	$91.00K
Revenue	-	-	-	$6.70M	$4.62M

Agenus's latest annual revenue breakdown by segment (product or service), as of Dec 24: Non Cash Royalty Revenue (98.05%), and Other (1.95%).

Quarterly Revenue by Product

Product/Service	Mar 25	Dec 24	Sep 24	Mar 24	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
Other	$510.00K	$1.55M	$454.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non Cash Royalty Revenue	$23.56M	$76.32M	$24.66M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research And Development Revenue	-	-	-	-	$3.41M	$2.49M	$2.61M	$3.75M	$4.57M	$1.91M	$6.74M	$1.71M	$1.57M	$11.63M	$4.29M	$18.07M	$1.93M	$18.82M	-	-
Revenue	-	-	-	$238.00K	$540.00K	$739.00K	$1.18M	$6.35M	$1.04M	$1.56M	$1.57M	$2.50M	$1.38M	$1.20M	$1.63M	$2.00M	$1.60M	$1.02M	-	-
Product And Service Other	-	-	-	-	-	-	-	-	-	-	-	$149.00K	-	-	$35.00K	$39.00K	-	$8.00K	$44.00K	$226.00K

Agenus's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Non Cash Royalty Revenue (97.88%), and Other (2.12%).

Agenus Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
UNITED STATES	$101.46M	$114.57M	$9.54M	$288.96M	$83.55M
Non-US	$2.00M	-	-	-	-
Non Us	-	-	-	$6.70M	-
Rest Of World	-	-	-	-	$4.62M

Agenus's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (98.06%), and Non-US (1.94%).

Quarterly Revenue by Country

Country	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
Non-US	$510.00K	$1.55M	$454.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
UNITED STATES	$23.56M	$49.03M	$24.66M	$27.77M	$89.82M	$20.36M	$2.04M	$2.35M	$18.28M	$4.45M	$19.37M	$24.37M	$17.76M	$9.53M	$10.09M	$29.31M	$13.23M	$25.92M	$15.08M	-
Non Us	-	-	-	-	-	-	-	-	-	-	$1.56M	$1.57M	$2.50M	$1.38M	$1.20M	$1.63M	$1.95M	$1.60M	$1.02M	-
U S	-	-	-	-	-	-	-	-	-	-	-	-	-	$251.58M	-	-	-	-	-	-
Europe	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$44.00K

Agenus's latest quarterly revenue breakdown by geography, as of Mar 25: UNITED STATES (97.88%), and Non-US (2.12%).

Agenus Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
MRKR	Marker Therapeutics	$6.59T	$349.10K
MDGL	Madrigal Pharmaceuticals	$180.13M	$137.25M
ADAP	Adaptimmune Therapeutics	$178.03M	$7.29M
AGEN	Agenus	$103.46M	$24.07M
ADCT	ADC Therapeutics SA	$69.28M	$16.91M
AFMD	Affimed	$8.28M	$155.00K
XFOR	X4 Pharmaceuticals	$2.56M	$28.81M
VKTX	Viking Therapeutics	-	-
TGTX	TG Therapeutics	-	$108.19M
EWTX	Edgewise Therapeutics	-	-
PDSB	PDS Bio	-	-
LPTX	Leap Therapeutics	-	-
MREO	Mereo BioPharma Group	-	-

AGEN Revenue FAQ

What is Agenus’s yearly revenue?

Agenus's yearly revenue for 2024 was $103.46M, representing a decrease of -33.81% compared to 2023. The company's yearly revenue for 2023 was $156.31M, representing an increase of 59.47% compared to 2022. AGEN's yearly revenue for 2022 was $98.02M, representing a decrease of -66.85% compared to 2021.

What is Agenus’s quarterly revenue?

Agenus's quarterly revenue for Q1 2025 was $24.07M, a -10.33% decrease from the previous quarter (Q4 2024), and a -14.07% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $26.84M, a 6.87% increase from the previous quarter (Q3 2024), and a -67.98% decrease year-over-year (Q4 2023). AGEN's quarterly revenue for Q3 2024 was $25.11M, a 6.82% increase from the previous quarter (Q2 2024), and a 3.28% increase year-over-year (Q3 2023).

What is Agenus’s revenue growth rate?

Agenus's revenue growth rate for the last 3 years (2022-2024) was 5.55%, and for the last 5 years (2020-2024) was 17.34%.

What are Agenus’s revenue streams?

Agenus's revenue streams in c 24 are Non Cash Royalty Revenue, and Other. Non Cash Royalty Revenue generated $100.98M in revenue, accounting 98.05% of the company's total revenue, down -11.87% year-over-year. Other generated $2M in revenue, accounting 1.95% of the company's total revenue

What is Agenus’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Agenus was Non Cash Royalty Revenue. This segment made a revenue of $100.98M, representing 98.05% of the company's total revenue.